Press Enter to search · ESC to close

US Stocks

J&J to acquire Ollin Biosciences for up to $3.4B

Johnson & Johnson plans to acquire Ollin Biosciences for up to $3.4 billion, with the deal potentially announced as soon as Monday. The transaction would mark one of the largest recent acquisitions in the biotech sector. No further terms or closing timeline were disclosed.

Share

Related News

Cointime share card
Long-press image above → Save to Photos / Share
Pitch us Community Feedback